NCT00498654View on ClinicalTrials.gov

Dose Ranging Study to Determine the Safety, Reactogenicity and Immunogenicity of Typhoid Fever Vaccine (Ty800) in Healthy Adult Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

October 31, 2007

Study Completion Date

June 30, 2008

Conditions
Typhoid Fever
Interventions
BIOLOGICAL

Ty800 (Salmonella typhi) Oral Vaccine

Trial Locations (5)

32935

Accelovance LLC, Melbourne

46601

Accelovance LLC, South Bend

61602

Accelovance LLC, Peoria

77024

Accelovance LLC, Houston

92108

Accelovance LLC, San Diego

Sponsors
All Listed Sponsors
lead

Avant Immunotherapeutics

INDUSTRY